"Advancing Quality of Care for Tuberous Sclerosis Complex Patients" was a session at the iPharma conference (May 2014) in which officials from Inspire, Tuberous Sclerosis Alliance and Novartis discussed the power of patient engagement and online patient communities.
Scleroderma Foundation/Inspire Support Community at a Glance Inspire
The Scleroderma Foundation/Inspire Support Community is the peer-to-peer resource for support and inspiration for people affected by the rare disease scleroderma.
This Presentation VMSA is all about the software technology to bring about various functionality for patients and other caretakers through the mobile application using Android and Cloud databases.
Scleroderma Foundation/Inspire Support Community at a Glance Inspire
The Scleroderma Foundation/Inspire Support Community is the peer-to-peer resource for support and inspiration for people affected by the rare disease scleroderma.
This Presentation VMSA is all about the software technology to bring about various functionality for patients and other caretakers through the mobile application using Android and Cloud databases.
Bristol-Myers Squibb: Making social content meaningful for patients, presente...SocialMedia.org
In her SocialMedia.org case study presentation, Bristol-Myers Squibb's Corporate Digital and Social Media Strategy Lead, Alison Woo, talks about how they focused on what matters to patients and key audiences in social media to create meaningful experiences.
The goal of the American Cancer society is to create a portal to educate cancer patients, caregivers, family and friends of cancer patients. This application seeks to remove the burden on the user by serving as a one stop solution for all the information the user needs to educate themselves about a family member’s diagnosis. Most importantly, the application will deliver personalized content to the user about the patient’s disease based on the patient’s diagnosis, treatment options for the diagnosis, drugs for treatment and the side effects associated with each drug. Users will also get tips on dealing with cancer patients and receive stories of hope.
There are four CEO's and a total of 13 healthcare professionals speaking at this event.
This program will be held at:
Holiday Inn Conference Center
7736 Adrienne Drive,
Breinigsville, PA 18031.
Inquiries may be directed to:
- Adam Hawk, Immediate Past President, HEF at ahawk@wellspan.org
- Christina Lewis, Program Chair, EPAHEN at christina.lewis@sluhn.org
Cost:
• $100 ACHE Member
• $150 Non-Member
• $60 Student
Register at: http://pa-odyssey2014.eventbrite.com
There are four CEO's and a total of 13 healthcare professionals speaking at this event.
This program will be held at:
Holiday Inn Conference Center
7736 Adrienne Drive,
Breinigsville, PA 18031.
Inquiries may be directed to:
- Adam Hawk, Immediate Past President, HEF at ahawk@wellspan.org
- Christina Lewis, Program Chair, EPAHEN at christina.lewis@sluhn.org
Cost:
• $100 ACHE Member
• $150 Non-Member
• $60 Student
Register at: http://pa-odyssey2014.eventbrite.com
Bringing the Social Media Revolution to Health Care (and Denmark)Lee Aase
My slides from a presentation at Mayo Clinic in Rochester, Minn. to visitors from Odense University Hospital and the Institute of Clinical Research at the University of Southern Denmark.
Crash course given for Lupus Europe in the Convention held in Helsinki in September 2014 to explain why it is so important that patient associations are into social media (Twitter, Facebook, etc.) and all what they can achieve by being social.
You may find more information and reports for this event at http://www.lupus-europe.org/activities/conventions/helsinki-2014/programme/session-details/article/leraning-about-social-media
MRN is focused on building community based clinical trials. We have seen that bringing the trial to the patient reduces burden and increases recruitment rate and achieves over 95% retention rates. Learn about the benefits here.
Design Trials to Better Satisfy Patient Centric Outcomes Prior to Product LaunchInspire
Incorporate Patient Participation – Design Trials to Better Satisfy Patient Centric Outcomes Prior to Product Launch
Presentation by Inspire Research Director Dave Taylor at Evidence for Value-Based Programs conference
August 12, 2015
Bristol-Myers Squibb: Making social content meaningful for patients, presente...SocialMedia.org
In her SocialMedia.org case study presentation, Bristol-Myers Squibb's Corporate Digital and Social Media Strategy Lead, Alison Woo, talks about how they focused on what matters to patients and key audiences in social media to create meaningful experiences.
The goal of the American Cancer society is to create a portal to educate cancer patients, caregivers, family and friends of cancer patients. This application seeks to remove the burden on the user by serving as a one stop solution for all the information the user needs to educate themselves about a family member’s diagnosis. Most importantly, the application will deliver personalized content to the user about the patient’s disease based on the patient’s diagnosis, treatment options for the diagnosis, drugs for treatment and the side effects associated with each drug. Users will also get tips on dealing with cancer patients and receive stories of hope.
There are four CEO's and a total of 13 healthcare professionals speaking at this event.
This program will be held at:
Holiday Inn Conference Center
7736 Adrienne Drive,
Breinigsville, PA 18031.
Inquiries may be directed to:
- Adam Hawk, Immediate Past President, HEF at ahawk@wellspan.org
- Christina Lewis, Program Chair, EPAHEN at christina.lewis@sluhn.org
Cost:
• $100 ACHE Member
• $150 Non-Member
• $60 Student
Register at: http://pa-odyssey2014.eventbrite.com
There are four CEO's and a total of 13 healthcare professionals speaking at this event.
This program will be held at:
Holiday Inn Conference Center
7736 Adrienne Drive,
Breinigsville, PA 18031.
Inquiries may be directed to:
- Adam Hawk, Immediate Past President, HEF at ahawk@wellspan.org
- Christina Lewis, Program Chair, EPAHEN at christina.lewis@sluhn.org
Cost:
• $100 ACHE Member
• $150 Non-Member
• $60 Student
Register at: http://pa-odyssey2014.eventbrite.com
Bringing the Social Media Revolution to Health Care (and Denmark)Lee Aase
My slides from a presentation at Mayo Clinic in Rochester, Minn. to visitors from Odense University Hospital and the Institute of Clinical Research at the University of Southern Denmark.
Crash course given for Lupus Europe in the Convention held in Helsinki in September 2014 to explain why it is so important that patient associations are into social media (Twitter, Facebook, etc.) and all what they can achieve by being social.
You may find more information and reports for this event at http://www.lupus-europe.org/activities/conventions/helsinki-2014/programme/session-details/article/leraning-about-social-media
MRN is focused on building community based clinical trials. We have seen that bringing the trial to the patient reduces burden and increases recruitment rate and achieves over 95% retention rates. Learn about the benefits here.
Design Trials to Better Satisfy Patient Centric Outcomes Prior to Product LaunchInspire
Incorporate Patient Participation – Design Trials to Better Satisfy Patient Centric Outcomes Prior to Product Launch
Presentation by Inspire Research Director Dave Taylor at Evidence for Value-Based Programs conference
August 12, 2015
La sclerosi multipla: dalla diagnosi alla personalizzazione della terapia. Materiale a cura del prof. Massimiliano Calabrese (Università di Verona) vincitore del “Premio di studio Maria Paola Belloni” - Alumni Università degli Studi di Padova
Beyond The Business Case For Diversity and Inclusion In TechWayne Sutton
Black History Month 2016 Talk
Tech companies released their diversity and inclusion data in 2014 that lead to the national awareness of the lack of inclusion in the workforce that has stifled innovation. Research after research continues to show that businesses with diverse leadership and employees outperform companies that are homogeneous yet many executives question the value of diversity. The conversation to-date still reflects how little progress has been made and what solutions are needed to create change and impact. Therefore, we must shift our strategies towards a more human-focused mindset to create empathic results for inclusion. This talk will explore strategies needed to go beyond the business case for diversity and inclusion in tech.
Focuses on Epilepsy Management for poeple wth Tuberous Sclerosis. Includes information on:
- Status Epilepticus
- Epilepsy Management
- First Aid Principles
- Seizure Management Planning
This is a deck I created to frame out my vision about healthcare and used in my job search. This is the exciting space in healthcare right now - communications, segmentation, data mining.
Tom Krohn, Business Lead for the Lilly Clinical Open Innovation Team, gave this presentation at the Patients at the Center of Clinical Research Workshop on Nov. 14, 2013.
In it, he discusses ways in which patients can become collaborators in drug development
Communicating the Case for Diversity and Inclusion Aerial Ellis
Addressing Imperatives: The growing requirement to address how workforce diversity has a quantifiable effect on business/performance outcomes, creates financial/economic benefits, and shifts organizational culture to impact greater human contribution; Assessing Implementation: The proactive effort that responds to the changing demographic profile of the workforce through the implementation of programs and services that support and empower a diverse workforce through multicultural approaches (ie. programs, initiatives, execution); Achieving Success: The return on investment (ROI) in terms of performance and economic outcomes that results from leveraging the variant knowledge, skills, abilities, talents, intellectual capital, perspectives, working styles, etc. of a diverse workforce (process-oriented).
TSC is neurocutaneous hereditary disorder either AD or sporadic characterized by multiple hamartomatous growths affecting skin, brain, heart, lung & kidney
In this presentation, Alison Coelho discusses the impact of migration on the sexual health of migrant communities in Victoria, Australia. This presentation was given at the Under the Baobab African Diaspora Networking Zone at the International AIDS Conference, AIDS 2014.
Why invest into infodemic management in health emergenciesTina Purnat
A lecture discussing the challenge of health misinformation and information ecosystem in public health, how this impacts demand promotion in health, and how this then relates to responding to misinformation and infodemics in health emergencies. Appended with lots of tools, guidance and resources for people who want to do more reading.
Exercise and cancer: How staying active can positively impact your health and...Inspire
In an hour-long webinar, nationally recognized exercise specialist Carol Michaels, MBA, ACE, ACSM discussed how maintaining an exercise program during cancer treatment and recovery can help patients to minimize treatment side effects, increase energy levels, and reduce stress, along with many other benefits. Inspire produced the educational webinar in partnership with the Bladder Cancer Advocacy Network, US TOO International, and ThyCa: Thyroid Cancer Survivors' Association.
Patient-centric social media for outcomes and pharmacovigilance consideration...Inspire
Through the use of de-identified Big Data from online patient forums open to healthcare providers, the pharmaceutical industry may glean useful insights into both the safety of existing products as well as future needs of patients. Post-marketing safety surveillance for pharmaceuticals currently relies on data from adverse event reports to companies or regulatory authorities, medical literature, and observational databases. Together these sources provide some insight into everyday product safety or risk, but the unique insight the patients themselves can offer is also highly desirable.
Using insights from a 2016 research project involving Inspire, GlaxoSmithKline (GSK) Pharmaceuticals, and Epidemico, an innovative informatics company, we are exploring the use of social listening data for pharmacovigilance and other R&D concerns. A core question is, “What valuable insights can we glean from social listening to help improve patients’ lives—whether through improved safety, more relevant clinical trials, or research and development of new treatment options?”
Successfully Navigating the Parent Landmines in the NICU Inspire
Deb Discenza of PreemieWorld and the Inspire Preemie Support Community, presents at the 9th Council of International Neonatal Nurses Conference (COINN), in August 2016.
Support Without Borders: The Ovarian Cancer Online CommunityInspire
Inspire CEO Brian Loew presents online research data to the national conference of the Ovarian Cancer Research Fund Alliance (OCRFA), an Inspire partner. The conference session took place July 10, 2016, in Washington, DC.
Experts by Experience 2016: A compilation of patient storiesInspire
In cooperation with Stanford Medicine, Inspire presents the special report, "Experts by Experience 2016: A compilation of patient stories," the fourth in an ongoing series.
Optimize Social Listening and Monitoring to Uncover Unmet Consumer NeedsInspire
Dave Taylor, director of research at Inspire, discusses ways that pharmaceutical and biotech companies can appropriately and effectively leverage social listening and monitoring. Taylor presented at the CBI BioPharma Social Media and Digital Platforms conference in February 2016 in Philadelphia, PA.
The "Pulmonary Fibrosis Patient/Caregiver Experience Survey" explored the experiences of people affected by pulmonary fibrosis. Inspire conducted the survey in cooperation with its partner, the Pulmonary Fibrosis Foundation (PFF). Inspire CEO Brian Loew presented the findings during the PFF Summit in Nov. 2015 in Washington, DC.
What Do Patients Really Want Out Of Adherence Technology?Inspire
Drawing insights from the 13,000-response Inspire Annual Survey, Dave Taylor, Inspire's director of research, presented at CBI’s Patient Adherence (PAAS) conference in Philadelphia, PA, in June 2015.
Advocacy in the Digital Age: Leveraging the Mental Health America/Inspire Sup...Inspire
Inspire CEO Brian Loew presented, "Advocacy in the Digital Age: Leveraging the Mental Health America/Inspire Support Community," at the June 2015 annual conference of nonprofit advocacy organization Mental Health America.
Insights into the e-Patient: An Analysis of the Inspire Annual SurveyInspire
"Insights into the e-Patient: An Analysis of the Inspire Annual Survey" was a presentation that Inspire's Dave Taylor made in May 2015 to the iPharma conference
Experts by Experience 2015: A compilation of patients’ storiesInspire
In cooperation with Stanford Medicine, Inspire presents "Experts by Experience 2015: A compilation of patients’ stories." The special report is the third in an ongoing series.
TalkPsoriasis is the largest online support community of people impacted by psoriasis or psoriatic arthritis. Sponsored by the National Psoriasis Foundation and Inspire, TalkPsoriasis is an open and encouraging environment where people affected by psoriasis or psoriatic arthritis can connect, exchange information, and meet friends.
Voice of the Empowered Patient: An Analysis of the Inspire Annual SurveyInspire
Inspire teamed with the trade organization Biotechnology Industry Organization for the seminar, “Connecting With the Empowered Patient in the Digital Age,” held Feb. 2015 at BIO headquarters in Washington, DC. The event brought together leaders from the patient advocacy community and life sciences industry to discuss how social media can be utilized to empower patients and engage advocates.
Inspire's Research Director Dave Taylor led the session, "Voice of the Empowered Patient: An Analysis of the Inspire Annual Survey."
Real World Takeaway Strategies for Successful PartnershipsInspire
Conference presentation by Claire Gill, National Osteoporosis Foundation, and Brian Loew of Inspire, on topic of online patient support communities and how nonprofit patient advocacy organizations are leveraging members to help further their mission. Gill and Loew discussed how pharma companies can connect effectively with nonprofit patient advocacy organizations.
Strategies and Tactics to Leverage Social and Digital Media in Clinical Rese...Inspire
Inspire CEO Brian Loew presents "Strategies and Tactics to Leverage Social and Digital Media in Clinical Research," at the 2014 conference of the Drug Information Association (DIA) in San Diego, CA.
Experts by experience 2014: A compilation of patients’ storiesInspire
Experts by experience 2014: A compilation of patients’ stories: A special report by Inspire, developed in cooperation with the Stanford University School of Medicine, featuring columns written by patients as part of a monthly series in Stanford University School of Medicine’s Scope medical blog.
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Advancing Quality of Care for Tuberous Sclerosis Complex Patients: A Case Study of Successful Partnership
1. !1
What is Inspire?
480,000 registered members
200 health communities
100 patient advocacy partners
2,500,000 visits per month
6,300,000 posts
900,000,000 words written
A social network, organized by health condition, that connects pharmaceutical companies with
patients and caregivers in a safe, permission-based manner.
2. !2
The Tuberous Sclerosis Alliance & Inspire support community
A partnership designed to support patients with tuberous sclerosis and their families, and
accelerate medical progress through voluntary engagement in research
3. Inspire’s partners in rare disease support & advocacy
90,000 patients & caregivers
!3
4. ABOUT THE TUBEROUS SCLEROSIS ALLIANCE
The Tuberous Sclerosis Alliance (TS Alliance), founded in
1974, is committed to finding a cure for tuberous sclerosis
complex (TSC) while improving the lives of those affected by:
• developing programs, support services and resource
information;
• stimulating and sponsoring research; and
• creating and implementing public and professional
education programs designed to heighten awareness of the
disease.
5. ABOUT TUBEROUS SCLEROSIS COMPLEX
• Tuberous sclerosis complex (or TSC) is a genetic disorder that causes
tumors to form in vital organs, primarily the brain, eyes, heart, kidney, liver,
lungs and skin.
• TSC affects ~1 in 6,000 live births.
• An estimated 50,000 Americans have TSC, and more than 1 million
worldwide.
• No two people are affected the same way, not even identical twins.
• Neurological manifestations are often the most devastating – affecting
almost all with TSC in some manner, from mild to severe.
• TSC is the leading genetic cause of autism and epilepsy.
6. HOW THE TS ALLIANCE USES SOCIAL MEDIA
• Early Days (Pre-2010):
– Previous online discussion groups were listserv-based, completely private,
difficult for constituents to utilize and to fit in, as well as challenging for the
TS Alliance staff to moderate.
– Four separate listservs were focused on different constituent groups:
adults with TSC, parents/caregivers, grandparents, TSC clinicians.
– 500 total participants.
• The Inspire TSC online platform helped connect our community
globally and across constituent groups and took the burden of
moderation from staff. The Inspire TSC Community now includes
2,279 members from 81 countries as of February 28. Individuals
focus on medical issues impacting quality of life.
• Social media is now a key component of our outreach/support
programs, promotional efforts and branding strategies.
7. HOW THE TS ALLIANCE USES SOCIAL MEDIA
Online discussion groups provide our constituents with instant access to:
– Peer support;
– Medical information; and
– Educational materials from the TS Alliance.
Inspire, Facebook and Twitter let us quickly and effectively:
– Conduct constituent surveys, research projects or crowd sourcing.
– Promote events, services and programs;
– Present the TS Alliance “brand” world-wide;
– Connect with new constituents; and
– Provide information and support as needed.
8. HOW THE TS ALLIANCE USES SOCIAL MEDIA
• YouTube allows organization to post educational and promotional
videos both on our branded YouTube channel and embedded on our
website.
• All social media properties allow staff to identify current trends and/or
concerns and then develop additional resources to address these
needs when appropriate. Inspire provides excellent tracking tools that
allow us to quickly assess these trends on a monthly basis.
9. Novartis is committed to serve patients with Rare
Diseases
1
! Novartis has a heritage of commitment to rare diseases, such as
TSC, focused on addressing patient needs.
! Novartis is committed to understanding and improving the lives of
people with TSC through clinical research, education and
collaboration with the TSC community.
! Novartis supports patient and healthcare professional organizations as
well as world-class researchers to help advance disease
awareness, knowledge sharing and additional research in the TSC
space.
10. Inspire support community allows for targeted
outreach to TSC patients & caregivers
1
Insights
! Generating patient/caregiver insights and understanding of
patient needs through anonymous online surveys
Education
! Disseminate educational materials around TSC disease
state to TSC community through one-way email outreach
Support
! Share information about Novartis products and patient
support services